Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Cuzick

Showing results (121-130 of 421) with videos related to

Pageof 43
Sort By:
Journal of the National Cancer Institute|September 2, 2017
Relevance of Spatial Heterogeneity of Immune Infiltration for Predicting Risk of Recurrence After Endocrine Therapy of ER+ Breast CancerAndreas Heindl, Ivana Sestak, Kalnisha Naidoo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2004
Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer TrialLesley Fallowfield, David Cella, Jack Cuzick, et al.
Journal of Medical Virology|November 19, 2002
Human papillomavirus DNA detection in the management of women with twice mildly abnormal cytological smearsLinda Ho, George Terry, Philip Londesborough, et al.
American Journal of Epidemiology|November 14, 2009
Determinants of percentage and area measures of mammographic densityJennifer Stone, Ruth M L Warren, Elizabeth Pinney, et al.
Ecancermedicalscience|December 5, 2015
Barriers to preventive therapy for breast and other major cancers and strategies to improve uptakeAndrea DeCensi, Mangesh A Thorat, Bernardo Bonanni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2010
Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trialIvana Sestak, Wolfgang Distler, John F Forbes, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 7, 2019
Role of HPV Genotype, Multiple Infections, and Viral Load on the Risk of High-Grade Cervical NeoplasiaRachael Adcock, Jack Cuzick, William C Hunt, et al.
Gynecologic Oncology|February 11, 2014
Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive womenNataša Vasiljević, Dorota Scibior-Bentkowska, Adam R Brentnall, et al.
Journal of the National Cancer Institute|April 22, 2004
Tamoxifen and breast density in women at increased risk of breast cancerJack Cuzick, Jane Warwick, Elizabeth Pinney, et al.
European Journal of Cancer (Oxford, England : 1990)|July 27, 2012
A double-blind placebo-controlled study to evaluate endometrial safety and gynaecological symptoms in women treated for up to 5 years with tamoxifen or placebo - a substudy for IBIS I Breast Cancer Prevention TrialTiina Palva, Hannu Ranta, Anna-Maija Koivisto, et al.
Pageof 43

Showing results (121-130 of 421) with videos related to

Sort By:
Pageof 43
Journal of the National Cancer Institute|September 2, 2017
Relevance of Spatial Heterogeneity of Immune Infiltration for Predicting Risk of Recurrence After Endocrine Therapy of ER+ Breast CancerAndreas Heindl, Ivana Sestak, Kalnisha Naidoo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2004
Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer TrialLesley Fallowfield, David Cella, Jack Cuzick, et al.
Journal of Medical Virology|November 19, 2002
Human papillomavirus DNA detection in the management of women with twice mildly abnormal cytological smearsLinda Ho, George Terry, Philip Londesborough, et al.
American Journal of Epidemiology|November 14, 2009
Determinants of percentage and area measures of mammographic densityJennifer Stone, Ruth M L Warren, Elizabeth Pinney, et al.
Ecancermedicalscience|December 5, 2015
Barriers to preventive therapy for breast and other major cancers and strategies to improve uptakeAndrea DeCensi, Mangesh A Thorat, Bernardo Bonanni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2010
Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trialIvana Sestak, Wolfgang Distler, John F Forbes, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 7, 2019
Role of HPV Genotype, Multiple Infections, and Viral Load on the Risk of High-Grade Cervical NeoplasiaRachael Adcock, Jack Cuzick, William C Hunt, et al.
Gynecologic Oncology|February 11, 2014
Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive womenNataša Vasiljević, Dorota Scibior-Bentkowska, Adam R Brentnall, et al.
Journal of the National Cancer Institute|April 22, 2004
Tamoxifen and breast density in women at increased risk of breast cancerJack Cuzick, Jane Warwick, Elizabeth Pinney, et al.
European Journal of Cancer (Oxford, England : 1990)|July 27, 2012
A double-blind placebo-controlled study to evaluate endometrial safety and gynaecological symptoms in women treated for up to 5 years with tamoxifen or placebo - a substudy for IBIS I Breast Cancer Prevention TrialTiina Palva, Hannu Ranta, Anna-Maija Koivisto, et al.
Pageof 43